| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |